Journal Information
Vol. 42. Issue 4.
Pages 206 (April 2006)
Vol. 42. Issue 4.
Pages 206 (April 2006)
Cartas al director
DOI: 10.1157/13086629
Full text access
Bronquiectasias y macrólidos
Visits
9742
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
L. Máiz Carro.
Tratamiento con azitromicina a largo plazo en un paciente con bronquiectasias idiopáticas.
Arch Bronconeumol, 41 (2005), pp. 295-296
[2.]
A. Jaffe, A. Bush.
Anti-inflammatory effects of macrolides in lung disease.
Pediatr Pulmonol, 31 (2001), pp. 464-473
[3.]
N. Oligaki.
Bacterial biofilm in chronic airway infection.
Kasenshogaku Zasshi, 68 (1994), pp. 138-151
[4.]
G.W. Amsden.
Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?.
J Antimicrob Chemother, 55 (2005), pp. 10-21
[5.]
B.K. Rubin, M.O. Henke.
Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
Chest, 125 (2004), pp. 70-78
[6.]
P. Scheinberg, E. Shore, On behalf of the PC-TNDS-008 Study Group.
A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
Chest, 127 (2005), pp. 1420-1426
Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica